コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ion of adolescent-onset, isolated hereditary spastic paraplegia.
2 developmental defects and a familial form of spastic paraplegia.
3 has been associated with a familial form of spastic paraplegia.
4 stin are the most common cause of hereditary spastic paraplegia.
5 s been linked to SPG13, a form of hereditary spastic paraplegia.
6 e human gene mutated in a form of hereditary spastic paraplegia.
7 stin is mutated in the axonopathy hereditary spastic paraplegia.
8 amyotrophic lateral sclerosis and hereditary spastic paraplegia.
9 PG3A, a common autosomal dominant hereditary spastic paraplegia.
10 e usual clinical presentation of progressive spastic paraplegia.
11 lly involved in MND, particularly hereditary spastic paraplegia.
12 1 (UBAP1) gene, which co-segregated with the spastic paraplegia.
13 hain gene KIF5A, in a family with hereditary spastic paraplegia.
14 es leads to phenotypes resembling hereditary spastic paraplegia.
15 nt with mild Pelizaeus-Merzbacher disease or spastic paraplegia.
16 g disorders such as Pelizaeus-Merzbacher and spastic paraplegia.
17 ch's ataxia, Wilson's disease and hereditary spastic paraplegia.
18 presenting with a complex form of hereditary spastic paraplegia.
19 nd developmental brain abnormalities to pure spastic paraplegia.
20 15 (SPG15), a complicated form of hereditary spastic paraplegia.
21 apitulates phenotypic features of hereditary spastic paraplegia.
22 ndings that overlap with both cutis laxa and spastic paraplegia.
23 rodegenerative diseases including hereditary spastic paraplegia.
24 esentation was a pure lower limb predominant spastic paraplegia.
25 izes the genetic heterogeneity of hereditary spastic paraplegia.
26 s in UBAP1 can cause pure autosomal dominant spastic paraplegia.
27 irst causal treatment strategy in hereditary spastic paraplegia.
28 tin, is the chief gene mutated in hereditary spastic paraplegia.
29 over time show progressive motor symptoms, a spastic paraplegia.
30 od model system for understanding hereditary spastic paraplegia.
31 dered the most frequent metabolic hereditary spastic paraplegia.
32 e, highlighting the genetic heterogeneity of spastic paraplegia.
33 s, consistent with a diagnosis of hereditary spastic paraplegia.
34 to motor neuron diseases, such as hereditary spastic paraplegia.
35 uting factor to early autonomic symptoms and spastic paraplegia.
36 h define a diverse set of complex hereditary spastic paraplegias.
40 d adaptive immune cells in a murine model of spastic paraplegia 15 (SPG15), a complicated form of her
41 and splice-site) associated with hereditary spastic paraplegia 4 (HSP-SPG4) (SPG4:OMIM#182601) has s
42 (mutations in which cause autosomal-dominant spastic paraplegia 4 [SPG4]) have been described, their
43 ation in ENTPD1, a gene previously linked to spastic paraplegia 64 (Mendelian Inheritance in Man # 61
44 diverse cellular activities (m-AAA) protease spastic paraplegia 7 (SPG7) has been recently implicated
45 dentified a necessary and conserved role for spastic paraplegia 7 (SPG7) in Ca(2+)- and ROS-induced P
46 23), Klip-Feil syndrome (8q22.2), hereditary spastic paraplegia (8q24), and benign adult familial myo
47 ype 5 (SPG5) is a rare subtype of hereditary spastic paraplegia, a highly heterogeneous group of neur
48 sociated with various subtypes of hereditary spastic paraplegia, a highly heterogeneous group of neur
50 been identified in patients with hereditary spastic paraplegias, a diverse group of neurological dis
51 encoding a later step, result in hereditary spastic paraplegia accompanied by intellectual deficits.
52 sense mutations in AP5Z1 and presenting with spastic paraplegia accompanied by neuropathy, parkinsoni
53 cular features of AP-4-associated hereditary spastic paraplegia across the age spectrum our results w
56 lies with autosomal dominant pure hereditary spastic paraplegia (ADPHSP), to examine the relative fre
57 eration: many candidate genes for hereditary spastic paraplegia also have central roles in lipid-drop
58 's disease, Huntington's disease, hereditary spastic paraplegia, amyotrophic lateral sclerosis, and C
59 tified in genes usually associated with pure spastic paraplegia and also in the Parkinson's disease-a
60 utant identified in patients with hereditary spastic paraplegia and associated with disrupted ESCRT f
61 Next, we screened a cohort of hereditary spastic paraplegia and cerebellar ataxia cases (n = 618)
64 a disease gene for a new complex hereditary spastic paraplegia and confirm that etherlipid homeostas
65 e fusion gene data could explain a report of spastic paraplegia and dementia cosegregating in a famil
67 patients suffering from SPG4-type hereditary spastic paraplegia and explain why single amino acid exc
68 ncreased EAE-related mortality, nonremitting spastic paraplegia and hemorrhagic inflammatory lesions.
69 in 24 cases in human neuropathies including spastic paraplegia and hereditary sensory and autonomic
70 in neurological disorders such as hereditary spastic paraplegia and hereditary sensory neuropathy.
71 erosis, infantile-onset ascending hereditary spastic paraplegia and juvenile primary lateral sclerosi
72 milies with an autosomal dominant hereditary spastic paraplegia and lacking mutations in known heredi
73 ns with intellectual disability, progressive spastic paraplegia and short stature, born to a consangu
76 ng as a candidate key pathway for hereditary spastic paraplegias and cerebellar ataxias and thus prio
77 h rare movement disorders such as hereditary spastic paraplegias and cerebellar ataxias remain geneti
78 pedigrees with autosomal dominant hereditary spastic paraplegias and lacking mutations in known causa
80 bone and frontotemporal dementia, hereditary spastic paraplegia, and 1-2% of familial amyotrophic lat
81 ith spastic paraparesis mimicking hereditary spastic paraplegia, and a multiple sclerosis-like illnes
83 s callosum hypoplasia, retardation, aphasia, spastic paraplegia, and hydrocephalus), and L1 knock-out
85 n is mutated in the human disease hereditary spastic paraplegia, and its link to WASH suggests that m
87 in the neurodegenerative disease hereditary spastic paraplegia, and of ichthyin, mutated in autosoma
89 autonomic neuropathy, complicated hereditary spastic paraplegia, and select hereditary metabolic neur
90 ions were found in patients with ichthyosis, spastic paraplegia, and severe neurodevelopmental defect
91 ost common locus for mutations in hereditary spastic paraplegias, and katanin are related microtubule
92 e most common autosomal recessive hereditary spastic paraplegias, and the SPG11 protein spatacsin for
93 4 (AP-4) leads to childhood-onset hereditary spastic paraplegia (AP-4-HSP): SPG47 (AP4B1), SPG50 (AP4
103 r ataxias and autosomal recessive hereditary spastic paraplegias (ARHSPs) are clinically and genetica
104 utosomal dominant pure or complex hereditary spastic paraplegia, as well as in two sporadic patients.
105 tion channel, in individuals with hereditary spastic paraplegias associated with mild intellectual di
106 assified as a complicated form of hereditary spastic paraplegia, associated with mutation in the etha
107 tion variants who presented with early onset spastic paraplegia, ataxia, optic nerve hypoplasia, and
108 ncluded neurodevelopmental delay, hypotonia, spastic paraplegia, brain white matter loss, and dysmorp
109 utations in REEP1 and REEP2 cause Hereditary Spastic Paraplegia, but the function of these four REEP
110 in NTE have been shown to cause a Hereditary Spastic Paraplegia called NTE-related Motor-Neuron Disor
111 l longer axons, and support a model in which spastic paraplegia can be caused by impairment of axonal
112 gait (SPG)1 to -57], over half of hereditary spastic paraplegia cases are caused by pathogenic mutati
113 broad pools of previously unknown hereditary spastic paraplegia causative genes and subtypes, we perf
114 yndrome is an autosomal recessive hereditary spastic paraplegia caused by mutation in the spartin (SP
115 totypical form of childhood-onset hereditary spastic paraplegia characterized by mislocalization of t
117 eterozygous female member were affected with spastic paraplegia characterized by relatively late onse
119 ven to these patients included dementia with spastic paraplegia, corticobasal degeneration syndrome,
120 ave been linked to diseases such as familial spastic paraplegia, developmental delay with premature d
121 ein KIF5A have been implicated to hereditary spastic paraplegia disease (HSP), a lethal neurodegenera
122 , spinal cord injury, stiff-person syndrome, spastic paraplegia, dystonia and Parkinson disease.
123 gical disorders, particularly the hereditary spastic paraplegias, emphasizing the importance of prope
130 o most common autosomal recessive hereditary spastic paraplegia gene products, the SPG15 protein spas
133 variants in a number of other known complex spastic paraplegia genes, including five in SPG7 (5/97),
134 bellar ataxia type 2, ataxia telangiectasia, spastic paraplegia, giant axonal neuropathy, and fumarat
138 neuromuscular diseases including hereditary spastic paraplegia, hereditary sensory neuropathy type 1
139 ociated neurodegeneration, FAHN), hereditary spastic paraplegia (HSP type SPG35) and leukodystrophy (
141 lt in similar problems that cause hereditary spastic paraplegia (HSP) and Charcot-Marie-Tooth type 2
142 of upper and lower motor neurons, hereditary spastic paraplegia (HSP) and distal hereditary motor neu
143 autosomal recessive (AR) complex hereditary spastic paraplegia (HSP) and juvenile onset amyotrophic
146 yndrome is an autosomal recessive hereditary spastic paraplegia (HSP) caused by frameshift mutations
149 cot-Marie-Tooth type 2 (CMT2) and Hereditary Spastic Paraplegia (HSP) depending on the affected neuro
152 of an autosomal-dominant gene for hereditary spastic paraplegia (HSP) in 10 families that are of dive
161 nt alleles of Atlastin-1 found in Hereditary Spastic Paraplegia (HSP) patients show similar ER phenot
162 n autosomal recessive complicated hereditary spastic paraplegia (HSP) that occurs with high frequency
165 reviously in complicated forms of hereditary spastic paraplegia (HSP) underlies progressive spastic p
166 milies with a complicated form of hereditary spastic paraplegia (HSP) who carry bi-allelic deleteriou
167 its four subunits cause a form of hereditary spastic paraplegia (HSP) with intellectual disability.
168 stin, strumpellin, or REEP1 cause hereditary spastic paraplegia (HSP), a disease characterized by axo
169 odegenerative diseases, including hereditary spastic paraplegia (HSP), a disorder characterized by sp
170 in an autosomal dominant form of hereditary spastic paraplegia (HSP), a motor-neurological disorder
171 e an unbranched ER morphology and hereditary spastic paraplegia (HSP), a neurodegenerative disease ch
172 stin are the most common cause of hereditary spastic paraplegia (HSP), a neurodegenerative disease th
173 tified in patients suffering from hereditary spastic paraplegia (HSP), a neurodegenerative disorder a
174 Mutations of various genes cause hereditary spastic paraplegia (HSP), a neurological disease involvi
175 plex, have been reported to cause hereditary spastic paraplegia (HSP), although their impact at the c
176 hy (SMA), Multiple Sclerosis (MS) Hereditary Spastic Paraplegia (HSP), and Huntington's Disease (HD).
177 A2 gene have been associated with hereditary spastic paraplegia (HSP), autosomal-recessive cerebellar
178 cot-Marie-Tooth disease (CMT) and Hereditary Spastic Paraplegia (HSP), but the mechanism of its invol
187 of autosomal-dominantly inherited hereditary spastic paraplegia (HSP-ATL1, SPG3A) with a predominantl
188 r neuron disease (MND), including hereditary spastic paraplegias (HSP), are associated with the death
205 The family of genes implicated in hereditary spastic paraplegias (HSPs) is quickly expanding, mostly
217 and by far the most common cause of complex spastic paraplegia in the UK, with severe and progressiv
218 set seizures, severe developmental delay and spastic paraplegia, in whom whole-genome sequencing reve
220 a and with a novel syndrome characterized by spastic paraplegia, intellectual disability, nystagmus a
221 INS220/ARMS in three unrelated patients with spastic paraplegia, intellectual disability, nystagmus,
222 paraplegia gene 11(SPG11)-linked hereditary spastic paraplegia is a complex monogenic neurodegenerat
226 form of pure, autosomal dominant hereditary spastic paraplegia is caused by mutation in the ATL1 gen
227 ommon form of autosomal recessive hereditary spastic paraplegia is caused by mutations in the SPG11/K
228 eurodegenerative disease that in addition to spastic paraplegia is characterized by childhood onset c
230 lower limb spasticity, or symptomatic, where spastic paraplegia is complicated by further neurologica
231 assified as either 'pure' or 'complex' where spastic paraplegia is complicated with additional neurol
232 nant lower limb spasticity, or complex where spastic paraplegia is complicated with additional neurol
235 10 and possibly of other forms of hereditary spastic paraplegia may involve perturbation of neuronal
236 ghter, muscular hypotonia that progressed to spastic paraplegia, microcephaly, foot deformity, decrea
237 tion is the main regulator of the hereditary spastic paraplegia microtubule severing enzyme spastin.
239 in produces similar phenotypes of hereditary spastic paraplegia (mitochondrial dysfunction and defect
240 functional defects of an atypical hereditary spastic paraplegia mutant, ATL1-F151S, that is impaired
241 egenerative disorder mainly characterized by spastic paraplegia, optic atrophy and neuropathy (SPOAN)
243 ew insights into the pathology of hereditary spastic paraplegia, particularly how mutations in multip
244 in the clinico-genetic work-up of hereditary spastic paraplegia, particularly in dominant cases, as t
249 , parkinsonism, muscle weakness, neuropathy, spastic paraplegia, personality/behavioral problems, and
250 y classified as a complex form of hereditary spastic paraplegia, present in families from Kuwait, Ita
252 rst demonstration of a role for a hereditary spastic paraplegia protein or ichthyin family member in
253 ity Gene2) and Bhlhb5 (mutated in Hereditary Spastic Paraplegia), providing a molecular handle to inv
254 ional progression rate of 0.56 points on the Spastic Paraplegia Rating Scale per year was slightly lo
257 ated a series of 97 index cases with complex spastic paraplegia referred to a tertiary referral neuro
259 characterization of patients with hereditary spastic paraplegias represents progressive spasticity, e
260 e cause Troyer syndrome, a recessive form of spastic paraplegia resulting in muscle weakness, short s
261 genic variants in SPTSSA caused a hereditary spastic paraplegia resulting in progressive motor distur
262 number of other diseases--including familial spastic paraplegia, schizophrenia, bipolar affective dis
267 lity syndrome, and three forms of hereditary spastic paraplegia, SPG11, SPG15 and SPG49 caused by SPG
268 t of families affected by autosomal dominant spastic paraplegia (SPG12-OMIM:604805) with a variable a
269 HD2 genes cause specific types of hereditary spastic paraplegia (SPG28 and SPG54, respectively), and
270 been identified in both a form of hereditary spastic paraplegia (SPG35) and a progressive familial le
272 ms of childhood-onset and complex hereditary spastic paraplegia: SPG47 (AP4B1), SPG50 (AP4M1), SPG51
273 had normal development with childhood-onset spastic paraplegia, spinal lesion, and optic atrophy.
275 cated form of autosomal-recessive hereditary spastic paraplegia termed AP-4-deficiency syndrome.
276 nd implies disease mechanisms for hereditary spastic paraplegia that involve dependence of the microt
277 greatly, ranging from muscular dystrophy to spastic paraplegia to a childhood blinding disorder to b
278 varying from juvenile-onset pure hereditary spastic paraplegia to infantile-onset spastic tetraplegi
279 s ranged from juvenile-onset pure hereditary spastic paraplegia to infantile-onset spasticity and glo
284 1A), GM3 synthase deficiency, and hereditary spastic paraplegia type 26 (HSPG26), each lacking effect
289 nder investigation; recent studies show that spastic paraplegia type 5, a progressive neuropathy, is
291 mutations cause a common form of hereditary spastic paraplegia, we suggest ER-shaping defects as a n
292 use an autosomal dominant form of hereditary spastic paraplegia, which is a retrograde axonopathy pri
293 Loss of B4GALNT1 function causes hereditary spastic paraplegia, while its overexpression is linked t
294 patients with adult onset leukodystrophy or spastic paraplegia with early onset of urinary symptoms
295 utations, and predominant complex hereditary spastic paraplegia with marked cognitive impairment, wit
296 es related to autosomal recessive hereditary spastic paraplegia with thin corpus callosum and axonal
297 uent cause of autosomal recessive hereditary spastic paraplegia with thin corpus callosum and periphe
298 cal findings were neurogenic bladder (100%), spastic paraplegia with vibration loss (90%), and axonal
299 late-onset, slowly progressive, complicated spastic paraplegia, with normal or near-normal psychomot
300 ly progressive type of cerebellar ataxia and spastic paraplegia, without intellectual disability.